Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – Should You Sell?

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) gapped down before the market opened on Wednesday . The stock had previously closed at $22.33, but opened at $21.6960. Daiichi Sankyo shares last traded at $21.4050, with a volume of 56,682 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Daiichi Sankyo has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Stock Down 4.2%

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The business’s 50 day moving average price is $22.36 and its 200 day moving average price is $23.72. The firm has a market cap of $40.52 billion and a PE ratio of 20.18.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.